Randomized phase II trial of neoadjuvant abiraterone plus or minus cabazitaxel in high-risk prostate cancer: ACDC-RP
Fleshner, Neil E., Hansen, Aaron Richard, Chin, Joseph, Winquist, Eric, Van Der Kwast, Theodorus, Lajkosz, Katherine, Kenk, Miran, Berlin, Doron, Veloso, Rosette, Sridhar, Srikala S., Hamilton, Robert James, Kulkarni, Girish S., Finelli, Antonio, Zlotta, Alexandre R., Joshua, Anthony M.
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial
Fleshner, Neil E., Sayyid, Rashid K., Hansen, Aaron R., Chin, Joseph L.K., Fernandes, Ricardo, Winquist, Eric, van der Kwast, Theodorus, Sweet, Joan, Lajkosz, Katherine, Kenk, Miran, Hersey, Karen, Veloso, Rosette, Berlin, Doron, Herrera-Caceres, Jaime O., Sridhar, Srikala, Moussa, Madeleine, Finelli, Antonio, Hamilton, Robert J., Kulkarni, Girish S., Zlotta, Alexandre R., Joshua, Anthony M.
Published in Clinical cancer research (02.10.2023)
Published in Clinical cancer research (02.10.2023)
Get full text
Journal Article
Neoadjuvant Cabazitaxel Plus Abiraterone/Leuprolide Acetate in High-Risk Prostate Cancer Patients: ACDC-RP Phase II Trial
Fleshner, Neil E, Sayyid, Rashid K, Hansen, Aaron R, Chin, Joseph L K, Fernandes, Ricardo, Winquist, Eric, van der Kwast, Theodorus, Sweet, Joan, Lajkosz, Katherine, Kenk, Miran, Hersey, Karen, Veloso, Rosette, Berlin, Doron, Herrera-Caceres, Jaime O, Sridhar, Srikala, Moussa, Madeleine, Finelli, Antonio, Hamilton, Robert J, Kulkarni, Girish S, Zlotta, Alexandre R, Joshua, Anthony M
Published in Clinical cancer research (13.07.2023)
Get full text
Published in Clinical cancer research (13.07.2023)
Journal Article